nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—ADRA2A—type 2 diabetes mellitus	0.12	0.42	CbGaD
Risperidone—HTR2C—type 2 diabetes mellitus	0.11	0.387	CbGaD
Risperidone—CYP3A4—type 2 diabetes mellitus	0.0551	0.193	CbGaD
Risperidone—HTR7—Bromocriptine—type 2 diabetes mellitus	0.0285	0.0661	CbGbCtD
Risperidone—DRD4—Bromocriptine—type 2 diabetes mellitus	0.0277	0.0643	CbGbCtD
Risperidone—HTR1D—Bromocriptine—type 2 diabetes mellitus	0.0228	0.0529	CbGbCtD
Risperidone—HTR2B—Bromocriptine—type 2 diabetes mellitus	0.0223	0.0518	CbGbCtD
Risperidone—HTR1B—Bromocriptine—type 2 diabetes mellitus	0.0219	0.0507	CbGbCtD
Risperidone—DRD3—Bromocriptine—type 2 diabetes mellitus	0.0206	0.0478	CbGbCtD
Risperidone—ADRA2C—Bromocriptine—type 2 diabetes mellitus	0.0198	0.046	CbGbCtD
Risperidone—DRD1—Bromocriptine—type 2 diabetes mellitus	0.0198	0.046	CbGbCtD
Risperidone—ADRA2B—Bromocriptine—type 2 diabetes mellitus	0.0188	0.0437	CbGbCtD
Risperidone—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0159	0.0369	CbGbCtD
Risperidone—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0145	0.0337	CbGbCtD
Risperidone—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0137	0.0318	CbGbCtD
Risperidone—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0131	0.0304	CbGbCtD
Risperidone—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0131	0.0304	CbGbCtD
Risperidone—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0125	0.0291	CbGbCtD
Risperidone—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0121	0.028	CbGbCtD
Risperidone—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0104	0.0242	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0104	0.0242	CbGbCtD
Risperidone—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0104	0.0242	CbGbCtD
Risperidone—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0093	0.0216	CbGbCtD
Risperidone—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.00783	0.0182	CbGbCtD
Risperidone—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00672	0.0156	CbGbCtD
Risperidone—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00634	0.0147	CbGbCtD
Risperidone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00625	0.0145	CbGbCtD
Risperidone—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00585	0.0136	CbGbCtD
Risperidone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00557	0.0129	CbGbCtD
Risperidone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0051	0.0118	CbGbCtD
Risperidone—CYP3A5—Losartan—type 2 diabetes mellitus	0.00484	0.0112	CbGbCtD
Risperidone—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0048	0.0111	CbGbCtD
Risperidone—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00462	0.0107	CbGbCtD
Risperidone—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0046	0.0107	CbGbCtD
Risperidone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00445	0.0103	CbGbCtD
Risperidone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00403	0.00935	CbGbCtD
Risperidone—ABCB1—Glyburide—type 2 diabetes mellitus	0.00344	0.00799	CbGbCtD
Risperidone—ABCB1—Losartan—type 2 diabetes mellitus	0.00315	0.00731	CbGbCtD
Risperidone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00305	0.00708	CbGbCtD
Risperidone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00293	0.00679	CbGbCtD
Risperidone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00293	0.00679	CbGbCtD
Risperidone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00277	0.00642	CbGbCtD
Risperidone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00206	0.00479	CbGbCtD
Risperidone—HTR7—sympathetic nervous system—type 2 diabetes mellitus	0.00198	0.0587	CbGeAlD
Risperidone—HTR2A—arteriole—type 2 diabetes mellitus	0.00194	0.0575	CbGeAlD
Risperidone—CYP3A4—Losartan—type 2 diabetes mellitus	0.00189	0.00438	CbGbCtD
Risperidone—HTR7—autonomic nervous system—type 2 diabetes mellitus	0.00133	0.0395	CbGeAlD
Risperidone—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00124	0.0366	CbGeAlD
Risperidone—DRD1—nerve—type 2 diabetes mellitus	0.0012	0.0355	CbGeAlD
Risperidone—HTR1B—artery—type 2 diabetes mellitus	0.000981	0.029	CbGeAlD
Risperidone—HTR7—peripheral nervous system—type 2 diabetes mellitus	0.000963	0.0285	CbGeAlD
Risperidone—HTR1D—artery—type 2 diabetes mellitus	0.00095	0.0281	CbGeAlD
Risperidone—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.000832	0.0246	CbGeAlD
Risperidone—HTR2A—hindlimb—type 2 diabetes mellitus	0.00077	0.0228	CbGeAlD
Risperidone—HTR7—artery—type 2 diabetes mellitus	0.000756	0.0224	CbGeAlD
Risperidone—HTR7—nerve—type 2 diabetes mellitus	0.00075	0.0222	CbGeAlD
Risperidone—DRD2—nerve—type 2 diabetes mellitus	0.00071	0.021	CbGeAlD
Risperidone—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000706	0.0209	CbGeAlD
Risperidone—HTR7—endothelium—type 2 diabetes mellitus	0.000639	0.0189	CbGeAlD
Risperidone—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.0006	0.0178	CbGeAlD
Risperidone—H1F0—islet of Langerhans—type 2 diabetes mellitus	0.000589	0.0174	CbGeAlD
Risperidone—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000544	0.0161	CbGeAlD
Risperidone—Paliperidone—ADRA2A—type 2 diabetes mellitus	0.000539	0.198	CrCbGaD
Risperidone—H1F0—retina—type 2 diabetes mellitus	0.000504	0.0149	CbGeAlD
Risperidone—Paliperidone—HTR2C—type 2 diabetes mellitus	0.000496	0.183	CrCbGaD
Risperidone—H1F0—nephron tubule—type 2 diabetes mellitus	0.000474	0.014	CbGeAlD
Risperidone—HTR2A—artery—type 2 diabetes mellitus	0.000472	0.014	CbGeAlD
Risperidone—HTR2A—nerve—type 2 diabetes mellitus	0.000468	0.0138	CbGeAlD
Risperidone—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000466	0.0138	CbGeAlD
Risperidone—ADRA1B—kidney—type 2 diabetes mellitus	0.000442	0.0131	CbGeAlD
Risperidone—H1F0—cardiovascular system—type 2 diabetes mellitus	0.000426	0.0126	CbGeAlD
Risperidone—H1F0—kidney—type 2 diabetes mellitus	0.000417	0.0123	CbGeAlD
Risperidone—H1F0—pancreas—type 2 diabetes mellitus	0.000414	0.0123	CbGeAlD
Risperidone—H1F0—cortex of kidney—type 2 diabetes mellitus	0.000406	0.012	CbGeAlD
Risperidone—HTR2A—endothelium—type 2 diabetes mellitus	0.000398	0.0118	CbGeAlD
Risperidone—Iloperidone—ADRA2A—type 2 diabetes mellitus	0.000377	0.139	CrCbGaD
Risperidone—H1F0—adipose tissue—type 2 diabetes mellitus	0.000376	0.0111	CbGeAlD
Risperidone—CYP3A7—liver—type 2 diabetes mellitus	0.000355	0.0105	CbGeAlD
Risperidone—Iloperidone—HTR2C—type 2 diabetes mellitus	0.000347	0.128	CrCbGaD
Risperidone—HTR1B—cardiovascular system—type 2 diabetes mellitus	0.000341	0.0101	CbGeAlD
Risperidone—KCNH2—islet of Langerhans—type 2 diabetes mellitus	0.000339	0.01	CbGeAlD
Risperidone—HTR1D—cardiovascular system—type 2 diabetes mellitus	0.00033	0.00977	CbGeAlD
Risperidone—HTR1D—kidney—type 2 diabetes mellitus	0.000323	0.00956	CbGeAlD
Risperidone—HTR2B—cardiovascular system—type 2 diabetes mellitus	0.000307	0.00909	CbGeAlD
Risperidone—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000302	0.00894	CbGeAlD
Risperidone—DRD2—retina—type 2 diabetes mellitus	0.000294	0.0087	CbGeAlD
Risperidone—HTR2B—cortex of kidney—type 2 diabetes mellitus	0.000293	0.00866	CbGeAlD
Risperidone—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.00028	0.00828	CbGeAlD
Risperidone—Iloperidone—CYP2E1—type 2 diabetes mellitus	0.000275	0.101	CrCbGaD
Risperidone—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000275	0.00814	CbGeAlD
Risperidone—HTR2B—adipose tissue—type 2 diabetes mellitus	0.000271	0.00801	CbGeAlD
Risperidone—ADRA2C—nephron tubule—type 2 diabetes mellitus	0.000269	0.00796	CbGeAlD
Risperidone—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000267	0.00789	CbGeAlD
Risperidone—H1F0—liver—type 2 diabetes mellitus	0.000263	0.0078	CbGeAlD
Risperidone—HTR7—cardiovascular system—type 2 diabetes mellitus	0.000263	0.00778	CbGeAlD
Risperidone—Iloperidone—CYP1A2—type 2 diabetes mellitus	0.000262	0.0964	CrCbGaD
Risperidone—HTR7—kidney—type 2 diabetes mellitus	0.000257	0.00761	CbGeAlD
Risperidone—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000254	0.0075	CbGeAlD
Risperidone—Paliperidone—CYP3A4—type 2 diabetes mellitus	0.000248	0.0912	CrCbGaD
Risperidone—KCNH2—cardiovascular system—type 2 diabetes mellitus	0.000245	0.00725	CbGeAlD
Risperidone—ADRA2C—kidney—type 2 diabetes mellitus	0.000236	0.007	CbGeAlD
Risperidone—ADRA2C—pancreas—type 2 diabetes mellitus	0.000235	0.00695	CbGeAlD
Risperidone—ADRA2C—cortex of kidney—type 2 diabetes mellitus	0.00023	0.00681	CbGeAlD
Risperidone—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000225	0.00666	CbGeAlD
Risperidone—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000224	0.00662	CbGeAlD
Risperidone—ADRA2C—adipose tissue—type 2 diabetes mellitus	0.000213	0.00631	CbGeAlD
Risperidone—CYP3A5—kidney—type 2 diabetes mellitus	0.000198	0.00586	CbGeAlD
Risperidone—CYP3A5—pancreas—type 2 diabetes mellitus	0.000197	0.00582	CbGeAlD
Risperidone—HTR2A—retina—type 2 diabetes mellitus	0.000194	0.00574	CbGeAlD
Risperidone—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000193	0.0057	CbGeAlD
Risperidone—ADRA2A—pancreas—type 2 diabetes mellitus	0.000187	0.00555	CbGeAlD
Risperidone—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000184	0.00544	CbGeAlD
Risperidone—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000178	0.00528	CbGeAlD
Risperidone—Iloperidone—CYP3A4—type 2 diabetes mellitus	0.000173	0.0638	CrCbGaD
Risperidone—HRH1—adipose tissue—type 2 diabetes mellitus	0.000173	0.00512	CbGeAlD
Risperidone—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.00017	0.00503	CbGeAlD
Risperidone—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000164	0.00485	CbGeAlD
Risperidone—HTR7—liver—type 2 diabetes mellitus	0.000163	0.00481	CbGeAlD
Risperidone—HTR2A—kidney—type 2 diabetes mellitus	0.00016	0.00475	CbGeAlD
Risperidone—ADRA1A—liver—type 2 diabetes mellitus	0.000157	0.00464	CbGeAlD
Risperidone—ADRA2C—liver—type 2 diabetes mellitus	0.000149	0.00442	CbGeAlD
Risperidone—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000149	0.0044	CbGeAlD
Risperidone—CYP3A4—kidney—type 2 diabetes mellitus	0.000148	0.00439	CbGeAlD
Risperidone—CYP2D6—kidney—type 2 diabetes mellitus	0.000146	0.00432	CbGeAlD
Risperidone—ABCB1—retina—type 2 diabetes mellitus	0.000127	0.00376	CbGeAlD
Risperidone—CYP3A5—liver—type 2 diabetes mellitus	0.000125	0.0037	CbGeAlD
Risperidone—ABCB1—nephron tubule—type 2 diabetes mellitus	0.00012	0.00354	CbGeAlD
Risperidone—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000107	0.00318	CbGeAlD
Risperidone—ABCB1—kidney—type 2 diabetes mellitus	0.000105	0.00311	CbGeAlD
Risperidone—ABCB1—pancreas—type 2 diabetes mellitus	0.000104	0.00309	CbGeAlD
Risperidone—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000102	0.00303	CbGeAlD
Risperidone—HTR2A—liver—type 2 diabetes mellitus	0.000101	0.003	CbGeAlD
Risperidone—ABCB1—adipose tissue—type 2 diabetes mellitus	9.47e-05	0.0028	CbGeAlD
Risperidone—CYP3A4—liver—type 2 diabetes mellitus	9.39e-05	0.00278	CbGeAlD
Risperidone—CYP2D6—liver—type 2 diabetes mellitus	9.24e-05	0.00273	CbGeAlD
Risperidone—ABCB1—liver—type 2 diabetes mellitus	6.64e-05	0.00197	CbGeAlD
Risperidone—Dyspnoea—Valsartan—type 2 diabetes mellitus	3.31e-05	0.000208	CcSEcCtD
Risperidone—Vertigo—Losartan—type 2 diabetes mellitus	3.31e-05	0.000208	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	3.31e-05	0.000208	CcSEcCtD
Risperidone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	3.31e-05	0.000207	CcSEcCtD
Risperidone—Somnolence—Valsartan—type 2 diabetes mellitus	3.3e-05	0.000207	CcSEcCtD
Risperidone—Syncope—Losartan—type 2 diabetes mellitus	3.3e-05	0.000207	CcSEcCtD
Risperidone—Paraesthesia—Orlistat—type 2 diabetes mellitus	3.29e-05	0.000207	CcSEcCtD
Risperidone—Leukopenia—Losartan—type 2 diabetes mellitus	3.29e-05	0.000207	CcSEcCtD
Risperidone—Discomfort—Irbesartan—type 2 diabetes mellitus	3.29e-05	0.000206	CcSEcCtD
Risperidone—Skin disorder—Metformin—type 2 diabetes mellitus	3.28e-05	0.000206	CcSEcCtD
Risperidone—Immune system disorder—Ramipril—type 2 diabetes mellitus	3.27e-05	0.000206	CcSEcCtD
Risperidone—Hyperhidrosis—Metformin—type 2 diabetes mellitus	3.27e-05	0.000205	CcSEcCtD
Risperidone—Dyspepsia—Valsartan—type 2 diabetes mellitus	3.27e-05	0.000205	CcSEcCtD
Risperidone—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	3.27e-05	0.000205	CcSEcCtD
Risperidone—Dizziness—Bromocriptine—type 2 diabetes mellitus	3.26e-05	0.000204	CcSEcCtD
Risperidone—Dry mouth—Irbesartan—type 2 diabetes mellitus	3.26e-05	0.000204	CcSEcCtD
Risperidone—Palpitations—Losartan—type 2 diabetes mellitus	3.25e-05	0.000204	CcSEcCtD
Risperidone—Nausea—Glimepiride—type 2 diabetes mellitus	3.24e-05	0.000204	CcSEcCtD
Risperidone—Arrhythmia—Ramipril—type 2 diabetes mellitus	3.24e-05	0.000203	CcSEcCtD
Risperidone—Loss of consciousness—Losartan—type 2 diabetes mellitus	3.23e-05	0.000203	CcSEcCtD
Risperidone—Nausea—Sitagliptin—type 2 diabetes mellitus	3.23e-05	0.000203	CcSEcCtD
Risperidone—Dyspepsia—Orlistat—type 2 diabetes mellitus	3.23e-05	0.000203	CcSEcCtD
Risperidone—Asthenia—Glyburide—type 2 diabetes mellitus	3.23e-05	0.000203	CcSEcCtD
Risperidone—Decreased appetite—Valsartan—type 2 diabetes mellitus	3.23e-05	0.000203	CcSEcCtD
Risperidone—Anorexia—Metformin—type 2 diabetes mellitus	3.22e-05	0.000202	CcSEcCtD
Risperidone—Cough—Losartan—type 2 diabetes mellitus	3.21e-05	0.000202	CcSEcCtD
Risperidone—Urticaria—Gliclazide—type 2 diabetes mellitus	3.21e-05	0.000202	CcSEcCtD
Risperidone—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	3.21e-05	0.000201	CcSEcCtD
Risperidone—Alopecia—Ramipril—type 2 diabetes mellitus	3.2e-05	0.000201	CcSEcCtD
Risperidone—Fatigue—Valsartan—type 2 diabetes mellitus	3.2e-05	0.000201	CcSEcCtD
Risperidone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	3.2e-05	0.000201	CcSEcCtD
Risperidone—Body temperature increased—Gliclazide—type 2 diabetes mellitus	3.2e-05	0.000201	CcSEcCtD
Risperidone—Oedema—Irbesartan—type 2 diabetes mellitus	3.19e-05	0.0002	CcSEcCtD
Risperidone—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	3.19e-05	0.0002	CcSEcCtD
Risperidone—Decreased appetite—Orlistat—type 2 diabetes mellitus	3.19e-05	0.0002	CcSEcCtD
Risperidone—Pruritus—Glyburide—type 2 diabetes mellitus	3.18e-05	0.0002	CcSEcCtD
Risperidone—Mental disorder—Ramipril—type 2 diabetes mellitus	3.18e-05	0.000199	CcSEcCtD
Risperidone—Constipation—Valsartan—type 2 diabetes mellitus	3.18e-05	0.000199	CcSEcCtD
Risperidone—Infection—Irbesartan—type 2 diabetes mellitus	3.17e-05	0.000199	CcSEcCtD
Risperidone—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	3.17e-05	0.000199	CcSEcCtD
Risperidone—Fatigue—Orlistat—type 2 diabetes mellitus	3.16e-05	0.000199	CcSEcCtD
Risperidone—Hypotension—Metformin—type 2 diabetes mellitus	3.16e-05	0.000198	CcSEcCtD
Risperidone—Malnutrition—Ramipril—type 2 diabetes mellitus	3.16e-05	0.000198	CcSEcCtD
Risperidone—Erythema—Ramipril—type 2 diabetes mellitus	3.16e-05	0.000198	CcSEcCtD
Risperidone—Shock—Irbesartan—type 2 diabetes mellitus	3.14e-05	0.000197	CcSEcCtD
Risperidone—Pain—Orlistat—type 2 diabetes mellitus	3.14e-05	0.000197	CcSEcCtD
Risperidone—Chest pain—Losartan—type 2 diabetes mellitus	3.13e-05	0.000197	CcSEcCtD
Risperidone—Arthralgia—Losartan—type 2 diabetes mellitus	3.13e-05	0.000197	CcSEcCtD
Risperidone—Myalgia—Losartan—type 2 diabetes mellitus	3.13e-05	0.000197	CcSEcCtD
Risperidone—Vomiting—Bromocriptine—type 2 diabetes mellitus	3.13e-05	0.000197	CcSEcCtD
Risperidone—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	3.13e-05	0.000196	CcSEcCtD
Risperidone—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	3.12e-05	0.000196	CcSEcCtD
Risperidone—Anxiety—Losartan—type 2 diabetes mellitus	3.12e-05	0.000196	CcSEcCtD
Risperidone—Tachycardia—Irbesartan—type 2 diabetes mellitus	3.11e-05	0.000196	CcSEcCtD
Risperidone—Rash—Bromocriptine—type 2 diabetes mellitus	3.1e-05	0.000195	CcSEcCtD
Risperidone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	3.1e-05	0.000195	CcSEcCtD
Risperidone—Skin disorder—Irbesartan—type 2 diabetes mellitus	3.1e-05	0.000195	CcSEcCtD
Risperidone—Tension—Ramipril—type 2 diabetes mellitus	3.1e-05	0.000194	CcSEcCtD
Risperidone—Discomfort—Losartan—type 2 diabetes mellitus	3.1e-05	0.000194	CcSEcCtD
Risperidone—Dysgeusia—Ramipril—type 2 diabetes mellitus	3.09e-05	0.000194	CcSEcCtD
Risperidone—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	3.09e-05	0.000194	CcSEcCtD
Risperidone—Headache—Bromocriptine—type 2 diabetes mellitus	3.08e-05	0.000194	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	3.08e-05	0.000193	CcSEcCtD
Risperidone—Diarrhoea—Glyburide—type 2 diabetes mellitus	3.08e-05	0.000193	CcSEcCtD
Risperidone—Nervousness—Ramipril—type 2 diabetes mellitus	3.06e-05	0.000192	CcSEcCtD
Risperidone—Dry mouth—Losartan—type 2 diabetes mellitus	3.06e-05	0.000192	CcSEcCtD
Risperidone—Anorexia—Irbesartan—type 2 diabetes mellitus	3.04e-05	0.000191	CcSEcCtD
Risperidone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	3.04e-05	0.000191	CcSEcCtD
Risperidone—Paraesthesia—Metformin—type 2 diabetes mellitus	3.04e-05	0.000191	CcSEcCtD
Risperidone—Muscle spasms—Ramipril—type 2 diabetes mellitus	3.03e-05	0.00019	CcSEcCtD
Risperidone—Confusional state—Losartan—type 2 diabetes mellitus	3.03e-05	0.00019	CcSEcCtD
Risperidone—Feeling abnormal—Orlistat—type 2 diabetes mellitus	3.02e-05	0.00019	CcSEcCtD
Risperidone—Dyspnoea—Metformin—type 2 diabetes mellitus	3.01e-05	0.000189	CcSEcCtD
Risperidone—Somnolence—Metformin—type 2 diabetes mellitus	3.01e-05	0.000189	CcSEcCtD
Risperidone—Anaphylactic shock—Losartan—type 2 diabetes mellitus	3e-05	0.000189	CcSEcCtD
Risperidone—Oedema—Losartan—type 2 diabetes mellitus	3e-05	0.000189	CcSEcCtD
Risperidone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	3e-05	0.000188	CcSEcCtD
Risperidone—Infection—Losartan—type 2 diabetes mellitus	2.98e-05	0.000187	CcSEcCtD
Risperidone—Hypotension—Irbesartan—type 2 diabetes mellitus	2.98e-05	0.000187	CcSEcCtD
Risperidone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	2.98e-05	0.000187	CcSEcCtD
Risperidone—Dyspepsia—Metformin—type 2 diabetes mellitus	2.98e-05	0.000187	CcSEcCtD
Risperidone—Tremor—Ramipril—type 2 diabetes mellitus	2.96e-05	0.000186	CcSEcCtD
Risperidone—Shock—Losartan—type 2 diabetes mellitus	2.95e-05	0.000185	CcSEcCtD
Risperidone—Urticaria—Valsartan—type 2 diabetes mellitus	2.95e-05	0.000185	CcSEcCtD
Risperidone—Nervous system disorder—Losartan—type 2 diabetes mellitus	2.95e-05	0.000185	CcSEcCtD
Risperidone—Thrombocytopenia—Losartan—type 2 diabetes mellitus	2.94e-05	0.000185	CcSEcCtD
Risperidone—Decreased appetite—Metformin—type 2 diabetes mellitus	2.94e-05	0.000185	CcSEcCtD
Risperidone—Abdominal pain—Valsartan—type 2 diabetes mellitus	2.94e-05	0.000184	CcSEcCtD
Risperidone—Tachycardia—Losartan—type 2 diabetes mellitus	2.93e-05	0.000184	CcSEcCtD
Risperidone—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	2.93e-05	0.000184	CcSEcCtD
Risperidone—Nausea—Bromocriptine—type 2 diabetes mellitus	2.92e-05	0.000184	CcSEcCtD
Risperidone—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	2.92e-05	0.000183	CcSEcCtD
Risperidone—Fatigue—Metformin—type 2 diabetes mellitus	2.92e-05	0.000183	CcSEcCtD
Risperidone—Urticaria—Orlistat—type 2 diabetes mellitus	2.91e-05	0.000183	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	2.91e-05	0.000183	CcSEcCtD
Risperidone—Hyperhidrosis—Losartan—type 2 diabetes mellitus	2.9e-05	0.000182	CcSEcCtD
Risperidone—Body temperature increased—Orlistat—type 2 diabetes mellitus	2.9e-05	0.000182	CcSEcCtD
Risperidone—Abdominal pain—Orlistat—type 2 diabetes mellitus	2.9e-05	0.000182	CcSEcCtD
Risperidone—Asthenia—Gliclazide—type 2 diabetes mellitus	2.9e-05	0.000182	CcSEcCtD
Risperidone—Agitation—Ramipril—type 2 diabetes mellitus	2.9e-05	0.000182	CcSEcCtD
Risperidone—Constipation—Metformin—type 2 diabetes mellitus	2.89e-05	0.000182	CcSEcCtD
Risperidone—Angioedema—Ramipril—type 2 diabetes mellitus	2.88e-05	0.000181	CcSEcCtD
Risperidone—Paraesthesia—Irbesartan—type 2 diabetes mellitus	2.87e-05	0.00018	CcSEcCtD
Risperidone—Anorexia—Losartan—type 2 diabetes mellitus	2.86e-05	0.00018	CcSEcCtD
Risperidone—Vomiting—Glyburide—type 2 diabetes mellitus	2.86e-05	0.00018	CcSEcCtD
Risperidone—Pruritus—Gliclazide—type 2 diabetes mellitus	2.86e-05	0.00018	CcSEcCtD
Risperidone—Malaise—Ramipril—type 2 diabetes mellitus	2.85e-05	0.000179	CcSEcCtD
Risperidone—Dyspnoea—Irbesartan—type 2 diabetes mellitus	2.85e-05	0.000179	CcSEcCtD
Risperidone—Rash—Glyburide—type 2 diabetes mellitus	2.84e-05	0.000178	CcSEcCtD
Risperidone—Somnolence—Irbesartan—type 2 diabetes mellitus	2.84e-05	0.000178	CcSEcCtD
Risperidone—Dermatitis—Glyburide—type 2 diabetes mellitus	2.84e-05	0.000178	CcSEcCtD
Risperidone—Vertigo—Ramipril—type 2 diabetes mellitus	2.83e-05	0.000178	CcSEcCtD
Risperidone—Syncope—Ramipril—type 2 diabetes mellitus	2.83e-05	0.000178	CcSEcCtD
Risperidone—Leukopenia—Ramipril—type 2 diabetes mellitus	2.82e-05	0.000177	CcSEcCtD
Risperidone—Headache—Glyburide—type 2 diabetes mellitus	2.82e-05	0.000177	CcSEcCtD
Risperidone—Dyspepsia—Irbesartan—type 2 diabetes mellitus	2.81e-05	0.000176	CcSEcCtD
Risperidone—Hypotension—Losartan—type 2 diabetes mellitus	2.81e-05	0.000176	CcSEcCtD
Risperidone—Palpitations—Ramipril—type 2 diabetes mellitus	2.79e-05	0.000175	CcSEcCtD
Risperidone—Feeling abnormal—Metformin—type 2 diabetes mellitus	2.79e-05	0.000175	CcSEcCtD
Risperidone—Decreased appetite—Irbesartan—type 2 diabetes mellitus	2.77e-05	0.000174	CcSEcCtD
Risperidone—Loss of consciousness—Ramipril—type 2 diabetes mellitus	2.77e-05	0.000174	CcSEcCtD
Risperidone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	2.77e-05	0.000174	CcSEcCtD
Risperidone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	2.77e-05	0.000174	CcSEcCtD
Risperidone—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	2.76e-05	0.000173	CcSEcCtD
Risperidone—Cough—Ramipril—type 2 diabetes mellitus	2.75e-05	0.000173	CcSEcCtD
Risperidone—Fatigue—Irbesartan—type 2 diabetes mellitus	2.75e-05	0.000173	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	2.74e-05	0.000172	CcSEcCtD
Risperidone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	2.74e-05	0.000172	CcSEcCtD
Risperidone—Convulsion—Ramipril—type 2 diabetes mellitus	2.73e-05	0.000172	CcSEcCtD
Risperidone—Pain—Irbesartan—type 2 diabetes mellitus	2.73e-05	0.000171	CcSEcCtD
Risperidone—Constipation—Irbesartan—type 2 diabetes mellitus	2.73e-05	0.000171	CcSEcCtD
Risperidone—Insomnia—Losartan—type 2 diabetes mellitus	2.72e-05	0.000171	CcSEcCtD
Risperidone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	2.7e-05	0.00017	CcSEcCtD
Risperidone—Paraesthesia—Losartan—type 2 diabetes mellitus	2.7e-05	0.000169	CcSEcCtD
Risperidone—Urticaria—Metformin—type 2 diabetes mellitus	2.69e-05	0.000169	CcSEcCtD
Risperidone—Chest pain—Ramipril—type 2 diabetes mellitus	2.69e-05	0.000169	CcSEcCtD
Risperidone—Arthralgia—Ramipril—type 2 diabetes mellitus	2.69e-05	0.000169	CcSEcCtD
Risperidone—Myalgia—Ramipril—type 2 diabetes mellitus	2.69e-05	0.000169	CcSEcCtD
Risperidone—Dyspnoea—Losartan—type 2 diabetes mellitus	2.68e-05	0.000168	CcSEcCtD
Risperidone—Anxiety—Ramipril—type 2 diabetes mellitus	2.68e-05	0.000168	CcSEcCtD
Risperidone—Nausea—Glyburide—type 2 diabetes mellitus	2.67e-05	0.000168	CcSEcCtD
Risperidone—Abdominal pain—Metformin—type 2 diabetes mellitus	2.67e-05	0.000168	CcSEcCtD
Risperidone—Dizziness—Gliclazide—type 2 diabetes mellitus	2.67e-05	0.000168	CcSEcCtD
Risperidone—Somnolence—Losartan—type 2 diabetes mellitus	2.67e-05	0.000168	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	2.67e-05	0.000167	CcSEcCtD
Risperidone—Asthenia—Valsartan—type 2 diabetes mellitus	2.66e-05	0.000167	CcSEcCtD
Risperidone—Discomfort—Ramipril—type 2 diabetes mellitus	2.65e-05	0.000167	CcSEcCtD
Risperidone—Dyspepsia—Losartan—type 2 diabetes mellitus	2.64e-05	0.000166	CcSEcCtD
Risperidone—Asthenia—Orlistat—type 2 diabetes mellitus	2.63e-05	0.000165	CcSEcCtD
Risperidone—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	2.63e-05	0.000165	CcSEcCtD
Risperidone—Pruritus—Valsartan—type 2 diabetes mellitus	2.63e-05	0.000165	CcSEcCtD
Risperidone—Dry mouth—Ramipril—type 2 diabetes mellitus	2.63e-05	0.000165	CcSEcCtD
Risperidone—Decreased appetite—Losartan—type 2 diabetes mellitus	2.61e-05	0.000164	CcSEcCtD
Risperidone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	2.61e-05	0.000164	CcSEcCtD
Risperidone—Confusional state—Ramipril—type 2 diabetes mellitus	2.6e-05	0.000163	CcSEcCtD
Risperidone—Pruritus—Orlistat—type 2 diabetes mellitus	2.6e-05	0.000163	CcSEcCtD
Risperidone—Fatigue—Losartan—type 2 diabetes mellitus	2.59e-05	0.000163	CcSEcCtD
Risperidone—Oedema—Ramipril—type 2 diabetes mellitus	2.58e-05	0.000162	CcSEcCtD
Risperidone—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	2.58e-05	0.000162	CcSEcCtD
Risperidone—Vomiting—Gliclazide—type 2 diabetes mellitus	2.57e-05	0.000161	CcSEcCtD
Risperidone—Pain—Losartan—type 2 diabetes mellitus	2.57e-05	0.000161	CcSEcCtD
Risperidone—Constipation—Losartan—type 2 diabetes mellitus	2.57e-05	0.000161	CcSEcCtD
Risperidone—Rash—Gliclazide—type 2 diabetes mellitus	2.55e-05	0.00016	CcSEcCtD
Risperidone—Dermatitis—Gliclazide—type 2 diabetes mellitus	2.55e-05	0.00016	CcSEcCtD
Risperidone—Diarrhoea—Valsartan—type 2 diabetes mellitus	2.54e-05	0.000159	CcSEcCtD
Risperidone—Urticaria—Irbesartan—type 2 diabetes mellitus	2.54e-05	0.000159	CcSEcCtD
Risperidone—Shock—Ramipril—type 2 diabetes mellitus	2.53e-05	0.000159	CcSEcCtD
Risperidone—Headache—Gliclazide—type 2 diabetes mellitus	2.53e-05	0.000159	CcSEcCtD
Risperidone—Nervous system disorder—Ramipril—type 2 diabetes mellitus	2.53e-05	0.000159	CcSEcCtD
Risperidone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	2.52e-05	0.000158	CcSEcCtD
Risperidone—Body temperature increased—Irbesartan—type 2 diabetes mellitus	2.52e-05	0.000158	CcSEcCtD
Risperidone—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	2.52e-05	0.000158	CcSEcCtD
Risperidone—Tachycardia—Ramipril—type 2 diabetes mellitus	2.51e-05	0.000158	CcSEcCtD
Risperidone—Diarrhoea—Orlistat—type 2 diabetes mellitus	2.51e-05	0.000158	CcSEcCtD
Risperidone—Skin disorder—Ramipril—type 2 diabetes mellitus	2.5e-05	0.000157	CcSEcCtD
Risperidone—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	2.49e-05	0.000156	CcSEcCtD
Risperidone—Feeling abnormal—Losartan—type 2 diabetes mellitus	2.47e-05	0.000155	CcSEcCtD
Risperidone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	2.46e-05	0.000154	CcSEcCtD
Risperidone—Dizziness—Valsartan—type 2 diabetes mellitus	2.46e-05	0.000154	CcSEcCtD
Risperidone—Anorexia—Ramipril—type 2 diabetes mellitus	2.45e-05	0.000154	CcSEcCtD
Risperidone—Dizziness—Orlistat—type 2 diabetes mellitus	2.43e-05	0.000152	CcSEcCtD
Risperidone—Asthenia—Metformin—type 2 diabetes mellitus	2.43e-05	0.000152	CcSEcCtD
Risperidone—Hypotension—Ramipril—type 2 diabetes mellitus	2.41e-05	0.000151	CcSEcCtD
Risperidone—Nausea—Gliclazide—type 2 diabetes mellitus	2.4e-05	0.000151	CcSEcCtD
Risperidone—Pruritus—Metformin—type 2 diabetes mellitus	2.39e-05	0.00015	CcSEcCtD
Risperidone—Urticaria—Losartan—type 2 diabetes mellitus	2.39e-05	0.00015	CcSEcCtD
Risperidone—Body temperature increased—Losartan—type 2 diabetes mellitus	2.37e-05	0.000149	CcSEcCtD
Risperidone—Abdominal pain—Losartan—type 2 diabetes mellitus	2.37e-05	0.000149	CcSEcCtD
Risperidone—Vomiting—Valsartan—type 2 diabetes mellitus	2.36e-05	0.000148	CcSEcCtD
Risperidone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	2.35e-05	0.000148	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	2.35e-05	0.000147	CcSEcCtD
Risperidone—Rash—Valsartan—type 2 diabetes mellitus	2.34e-05	0.000147	CcSEcCtD
Risperidone—Dermatitis—Valsartan—type 2 diabetes mellitus	2.34e-05	0.000147	CcSEcCtD
Risperidone—Vomiting—Orlistat—type 2 diabetes mellitus	2.33e-05	0.000146	CcSEcCtD
Risperidone—Insomnia—Ramipril—type 2 diabetes mellitus	2.33e-05	0.000146	CcSEcCtD
Risperidone—Headache—Valsartan—type 2 diabetes mellitus	2.33e-05	0.000146	CcSEcCtD
Risperidone—Diarrhoea—Metformin—type 2 diabetes mellitus	2.31e-05	0.000145	CcSEcCtD
Risperidone—Rash—Orlistat—type 2 diabetes mellitus	2.31e-05	0.000145	CcSEcCtD
Risperidone—Paraesthesia—Ramipril—type 2 diabetes mellitus	2.31e-05	0.000145	CcSEcCtD
Risperidone—Dermatitis—Orlistat—type 2 diabetes mellitus	2.31e-05	0.000145	CcSEcCtD
Risperidone—Headache—Orlistat—type 2 diabetes mellitus	2.3e-05	0.000144	CcSEcCtD
Risperidone—Dyspnoea—Ramipril—type 2 diabetes mellitus	2.3e-05	0.000144	CcSEcCtD
Risperidone—Asthenia—Irbesartan—type 2 diabetes mellitus	2.29e-05	0.000144	CcSEcCtD
Risperidone—Somnolence—Ramipril—type 2 diabetes mellitus	2.29e-05	0.000144	CcSEcCtD
Risperidone—Dyspepsia—Ramipril—type 2 diabetes mellitus	2.27e-05	0.000142	CcSEcCtD
Risperidone—Pruritus—Irbesartan—type 2 diabetes mellitus	2.26e-05	0.000142	CcSEcCtD
Risperidone—Decreased appetite—Ramipril—type 2 diabetes mellitus	2.24e-05	0.000141	CcSEcCtD
Risperidone—Dizziness—Metformin—type 2 diabetes mellitus	2.24e-05	0.00014	CcSEcCtD
Risperidone—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	2.22e-05	0.00014	CcSEcCtD
Risperidone—Fatigue—Ramipril—type 2 diabetes mellitus	2.22e-05	0.000139	CcSEcCtD
Risperidone—Hypersensitivity—Losartan—type 2 diabetes mellitus	2.21e-05	0.000139	CcSEcCtD
Risperidone—Nausea—Valsartan—type 2 diabetes mellitus	2.21e-05	0.000138	CcSEcCtD
Risperidone—Constipation—Ramipril—type 2 diabetes mellitus	2.2e-05	0.000138	CcSEcCtD
Risperidone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	2.18e-05	0.000137	CcSEcCtD
Risperidone—Nausea—Orlistat—type 2 diabetes mellitus	2.18e-05	0.000137	CcSEcCtD
Risperidone—Asthenia—Losartan—type 2 diabetes mellitus	2.15e-05	0.000135	CcSEcCtD
Risperidone—Vomiting—Metformin—type 2 diabetes mellitus	2.15e-05	0.000135	CcSEcCtD
Risperidone—Rash—Metformin—type 2 diabetes mellitus	2.13e-05	0.000134	CcSEcCtD
Risperidone—Dermatitis—Metformin—type 2 diabetes mellitus	2.13e-05	0.000134	CcSEcCtD
Risperidone—Pruritus—Losartan—type 2 diabetes mellitus	2.12e-05	0.000133	CcSEcCtD
Risperidone—Feeling abnormal—Ramipril—type 2 diabetes mellitus	2.12e-05	0.000133	CcSEcCtD
Risperidone—Headache—Metformin—type 2 diabetes mellitus	2.12e-05	0.000133	CcSEcCtD
Risperidone—Dizziness—Irbesartan—type 2 diabetes mellitus	2.11e-05	0.000132	CcSEcCtD
Risperidone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	2.11e-05	0.000132	CcSEcCtD
Risperidone—Diarrhoea—Losartan—type 2 diabetes mellitus	2.05e-05	0.000129	CcSEcCtD
Risperidone—Urticaria—Ramipril—type 2 diabetes mellitus	2.05e-05	0.000128	CcSEcCtD
Risperidone—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.04e-05	0.000128	CcSEcCtD
Risperidone—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.04e-05	0.000128	CcSEcCtD
Risperidone—Vomiting—Irbesartan—type 2 diabetes mellitus	2.03e-05	0.000127	CcSEcCtD
Risperidone—Rash—Irbesartan—type 2 diabetes mellitus	2.01e-05	0.000126	CcSEcCtD
Risperidone—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.01e-05	0.000126	CcSEcCtD
Risperidone—Nausea—Metformin—type 2 diabetes mellitus	2.01e-05	0.000126	CcSEcCtD
Risperidone—Headache—Irbesartan—type 2 diabetes mellitus	2e-05	0.000126	CcSEcCtD
Risperidone—Dizziness—Losartan—type 2 diabetes mellitus	1.99e-05	0.000125	CcSEcCtD
Risperidone—Vomiting—Losartan—type 2 diabetes mellitus	1.91e-05	0.00012	CcSEcCtD
Risperidone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	1.9e-05	0.000119	CcSEcCtD
Risperidone—Nausea—Irbesartan—type 2 diabetes mellitus	1.9e-05	0.000119	CcSEcCtD
Risperidone—Rash—Losartan—type 2 diabetes mellitus	1.89e-05	0.000119	CcSEcCtD
Risperidone—Dermatitis—Losartan—type 2 diabetes mellitus	1.89e-05	0.000119	CcSEcCtD
Risperidone—Headache—Losartan—type 2 diabetes mellitus	1.88e-05	0.000118	CcSEcCtD
Risperidone—Asthenia—Ramipril—type 2 diabetes mellitus	1.85e-05	0.000116	CcSEcCtD
Risperidone—Pruritus—Ramipril—type 2 diabetes mellitus	1.82e-05	0.000114	CcSEcCtD
Risperidone—Nausea—Losartan—type 2 diabetes mellitus	1.78e-05	0.000112	CcSEcCtD
Risperidone—Diarrhoea—Ramipril—type 2 diabetes mellitus	1.76e-05	0.000111	CcSEcCtD
Risperidone—Dizziness—Ramipril—type 2 diabetes mellitus	1.7e-05	0.000107	CcSEcCtD
Risperidone—Vomiting—Ramipril—type 2 diabetes mellitus	1.64e-05	0.000103	CcSEcCtD
Risperidone—Rash—Ramipril—type 2 diabetes mellitus	1.62e-05	0.000102	CcSEcCtD
Risperidone—Dermatitis—Ramipril—type 2 diabetes mellitus	1.62e-05	0.000102	CcSEcCtD
Risperidone—Headache—Ramipril—type 2 diabetes mellitus	1.61e-05	0.000101	CcSEcCtD
Risperidone—Nausea—Ramipril—type 2 diabetes mellitus	1.53e-05	9.6e-05	CcSEcCtD
Risperidone—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.44e-06	1.63e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.43e-06	1.63e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.43e-06	1.62e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.43e-06	1.62e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.42e-06	1.62e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—RELA—type 2 diabetes mellitus	1.42e-06	1.62e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.42e-06	1.62e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.41e-06	1.61e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.41e-06	1.61e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.41e-06	1.6e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	1.41e-06	1.6e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—RELA—type 2 diabetes mellitus	1.4e-06	1.59e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	1.4e-06	1.59e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.4e-06	1.59e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.39e-06	1.59e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.39e-06	1.59e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.39e-06	1.58e-05	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.39e-06	1.58e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.39e-06	1.58e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.38e-06	1.57e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.38e-06	1.57e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.38e-06	1.57e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.37e-06	1.56e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.37e-06	1.56e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.37e-06	1.56e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.37e-06	1.56e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.37e-06	1.55e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.37e-06	1.55e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.36e-06	1.55e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.36e-06	1.54e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.36e-06	1.54e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.36e-06	1.54e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.35e-06	1.54e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.35e-06	1.54e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.35e-06	1.54e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.35e-06	1.54e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.35e-06	1.53e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.35e-06	1.53e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.35e-06	1.53e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.35e-06	1.53e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	1.35e-06	1.53e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	1.35e-06	1.53e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.34e-06	1.53e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	1.34e-06	1.53e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.34e-06	1.52e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.34e-06	1.52e-05	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.34e-06	1.52e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.33e-06	1.52e-05	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.33e-06	1.51e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.33e-06	1.51e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.33e-06	1.51e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.33e-06	1.51e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.32e-06	1.51e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.32e-06	1.51e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.32e-06	1.5e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.32e-06	1.5e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.32e-06	1.5e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.32e-06	1.5e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.31e-06	1.49e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.31e-06	1.49e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.31e-06	1.49e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.3e-06	1.48e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.3e-06	1.48e-05	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.3e-06	1.47e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.29e-06	1.47e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.29e-06	1.47e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.29e-06	1.46e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.29e-06	1.46e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.28e-06	1.46e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.28e-06	1.46e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.28e-06	1.45e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.28e-06	1.45e-05	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.28e-06	1.45e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.27e-06	1.45e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.27e-06	1.44e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.27e-06	1.44e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.27e-06	1.44e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.27e-06	1.44e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.26e-06	1.44e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.26e-06	1.44e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.26e-06	1.43e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.26e-06	1.43e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.25e-06	1.43e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.25e-06	1.42e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.25e-06	1.42e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.24e-06	1.41e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.24e-06	1.41e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.23e-06	1.4e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	1.23e-06	1.4e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.23e-06	1.4e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.23e-06	1.4e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.22e-06	1.38e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.21e-06	1.38e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.21e-06	1.38e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.2e-06	1.37e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.2e-06	1.36e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.2e-06	1.36e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.19e-06	1.36e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.19e-06	1.35e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.18e-06	1.34e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.18e-06	1.34e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.18e-06	1.34e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.18e-06	1.34e-05	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.18e-06	1.34e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.17e-06	1.33e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.16e-06	1.32e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.16e-06	1.32e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.16e-06	1.32e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.16e-06	1.32e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.16e-06	1.32e-05	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.16e-06	1.32e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.16e-06	1.31e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.16e-06	1.31e-05	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.15e-06	1.31e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.15e-06	1.31e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.15e-06	1.3e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.14e-06	1.3e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.14e-06	1.29e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.14e-06	1.29e-05	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.13e-06	1.29e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.13e-06	1.28e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.12e-06	1.28e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.12e-06	1.27e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.12e-06	1.27e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.12e-06	1.27e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.11e-06	1.27e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.1e-06	1.25e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.1e-06	1.25e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.09e-06	1.24e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.09e-06	1.24e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.09e-06	1.24e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.09e-06	1.24e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.09e-06	1.24e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.09e-06	1.24e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.08e-06	1.23e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.08e-06	1.23e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.08e-06	1.22e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.07e-06	1.22e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.07e-06	1.22e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.07e-06	1.22e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.07e-06	1.22e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.07e-06	1.21e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.06e-06	1.21e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.06e-06	1.21e-05	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.05e-06	1.2e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—IL6—type 2 diabetes mellitus	1.05e-06	1.19e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.05e-06	1.19e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.05e-06	1.19e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.05e-06	1.19e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.05e-06	1.19e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—IL6—type 2 diabetes mellitus	1.04e-06	1.19e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.04e-06	1.19e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.04e-06	1.19e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.04e-06	1.18e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.03e-06	1.17e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.03e-06	1.17e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.03e-06	1.17e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.02e-06	1.16e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.02e-06	1.15e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.02e-06	1.15e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.02e-06	1.15e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.02e-06	1.15e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.01e-06	1.15e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.01e-06	1.15e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—IL6—type 2 diabetes mellitus	1.01e-06	1.14e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1e-06	1.14e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1e-06	1.14e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	9.99e-07	1.14e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	9.97e-07	1.13e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	9.97e-07	1.13e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.89e-07	1.12e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.86e-07	1.12e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.84e-07	1.12e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.8e-07	1.11e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	9.78e-07	1.11e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	9.76e-07	1.11e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.75e-07	1.11e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.73e-07	1.11e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	9.72e-07	1.11e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.71e-07	1.1e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.69e-07	1.1e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.65e-07	1.1e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.63e-07	1.1e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	9.6e-07	1.09e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	9.57e-07	1.09e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	9.57e-07	1.09e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.56e-07	1.09e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.52e-07	1.08e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	9.47e-07	1.08e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.43e-07	1.07e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	9.35e-07	1.06e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	9.29e-07	1.06e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.28e-07	1.06e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	9.09e-07	1.03e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.07e-07	1.03e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	9.06e-07	1.03e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	8.97e-07	1.02e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	8.94e-07	1.02e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.93e-07	1.02e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.91e-07	1.01e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.9e-07	1.01e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.86e-07	1.01e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.85e-07	1.01e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	8.8e-07	1e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	8.76e-07	9.95e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.75e-07	9.95e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.74e-07	9.94e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.73e-07	9.93e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.57e-07	9.75e-06	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	8.56e-07	9.73e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	8.53e-07	9.69e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	8.38e-07	9.53e-06	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.35e-07	9.5e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	8.35e-07	9.5e-06	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	8.31e-07	9.45e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	8.26e-07	9.39e-06	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.24e-07	9.37e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.12e-07	9.24e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	8.07e-07	9.17e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.96e-07	9.05e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.79e-07	8.85e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	7.75e-07	8.81e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	7.54e-07	8.57e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.44e-07	8.46e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	7.42e-07	8.43e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	7.28e-07	8.27e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.18e-07	8.17e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.15e-07	8.13e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	7.14e-07	8.11e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.95e-07	7.9e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.84e-07	7.78e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	6.84e-07	7.77e-06	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	6.75e-07	7.68e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.73e-07	7.65e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	6.71e-07	7.63e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.59e-07	7.49e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	6.54e-07	7.44e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.31e-07	7.17e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	6.26e-07	7.12e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	6.26e-07	7.12e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.21e-07	7.06e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.19e-07	7.04e-06	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	6.19e-07	7.04e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.12e-07	6.96e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.08e-07	6.91e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	5.72e-07	6.51e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.65e-07	6.42e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	4.67e-07	5.31e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	4.4e-07	5e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.88e-07	3.27e-06	CbGpPWpGaD
